Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.3.0.814
Consolidated Balance Sheets - USD ($)
Nov. 30, 2014
Nov. 30, 2013
CURRENT    
Cash and cash equivalents $ 1,085,006 $ 1,842,149
Accounts Receivable 7,393 20,351
Inventory 120,246 0
Deferred financing costs 170,674 0
Prepaid expenses and other receivables 29,557 45,372
Total Current Assets 1,412,876 1,907,872
Plant and Equipment 144,176 152,137
TOTAL ASSETS 1,557,052 2,060,009
CURRENT LIABILITIES    
Accounts payable and accrued liabilities 161,405 106,529
Total Current Liabilities 161,405 106,529
Convertible Debentures 1,398,592 0
Total Liabilities 1,559,997 106,529
Capital Stock    
Preferred stock, $0.001 par value, 5,000,000 shares authorized, Nil issued and outstanding (2013 - nil). The provisions in the Articles of Incorporation allow the directors to issue preferred stock with multiple votes per share and dividend rights, which would have priority over any dividends paid with respect to the holders of Company's common stock. 0 0
Common stock, $0.001 par value 100,000,000 shares authorized, 46,899,285 issued and outstanding (2013: 46,849,285) 46,899 46,849
Additional Paid-In Capital 24,024,631 23,226,988
Deficiency (24,042,769) (21,320,357)
Accumulated other comprehensive loss (31,706) 0
Total Stockholders' Equity (Deficiency) (2,945) 1,953,480
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIENCY) $ 1,557,052 $ 2,060,009